35
Participants
Start Date
January 31, 2017
Primary Completion Date
March 19, 2019
Study Completion Date
March 31, 2026
Pembrolizumab
"Pembrolizumab (prior to surgery) 200 mg IV over 30 min, days 1 \& 22, two cycles; followed by surgery; followed by standard adjuvant chemotherapy (per med. oncologist) +/- radiation therapy per institutional standard of care; followed by adjuvant pembrolizumab 200 mg IV over 30 min every 21 days for 4 cycles~-Note: Standard radiation therapy in selected patients for standard clinical indications"
Duke University Medical Center, Durham
Mayo Clinic, Rochester
Dartmouth-Hitchcock Medical Center, Lebanon
Merck Sharp & Dohme LLC
INDUSTRY
Neal Ready MD PhD
OTHER